AMED Amedisys Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMED

Price (delayed)

$79.47

Market cap

$2.59B

P/E Ratio

22.97

Dividend/share

N/A

EPS

$3.46

Enterprise value

$3B

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, ...

Highlights
The P/E is 34% below the 5-year quarterly average of 35.0 and 2.7% below the last 4 quarters average of 23.6
AMED's equity is up by 12% year-on-year and by 2.6% since the previous quarter
The net income has decreased by 41% YoY and by 5% QoQ
AMED's EPS is down by 41% YoY and by 5% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.amedisys.com
Peers: CHE NHC

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.56M
Market cap
$2.59B
Enterprise value
$3B
Valuations
Price to earnings (P/E)
22.97
Price to book (P/B)
2.4
Price to sales (P/S)
1.16
EV/EBIT
16.77
EV/EBITDA
12.2
EV/Sales
1.34
Earnings
Revenue
$2.23B
EBIT
$179.08M
EBITDA
$246.26M
Free cash flow
$104.04M
Per share
EPS
$3.46
Free cash flow per share
$3.2
Book value per share
$33.15
Revenue per share
$68.63
TBVPS
$18.5
Balance sheet
Total assets
$1.95B
Total liabilities
$813.61M
Debt
$485.44M
Equity
$1.08B
Working capital
$52.51M
Liquidity
Debt to equity
0.45
Current ratio
1.15
Quick ratio
1.03
Net debt/EBITDA
1.69
Margins
EBITDA margin
11%
Gross margin
43.1%
Net margin
5%
Operating margin
7.8%
Efficiency
Return on assets
5.7%
Return on equity
10.9%
Return on invested capital
25.3%
Return on capital employed
11.2%
Return on sales
8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
3.64%
1 week
2.79%
1 month
2.86%
1 year
-31.59%
YTD
-4.87%
QTD
8.05%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.23B
Gross profit
$963.72M
Operating income
$175.19M
Net income
$112.18M
Gross margin
43.1%
Net margin
5%
The company's net margin fell by 42% YoY and by 6% QoQ
The net income has decreased by 41% YoY and by 5% QoQ
The company's operating margin fell by 25% YoY and by 3.7% QoQ
AMED's operating income is down by 24% year-on-year and by 3.1% since the previous quarter

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
22.97
P/B
2.4
P/S
1.16
EV/EBIT
16.77
EV/EBITDA
12.2
EV/Sales
1.34
AMED's EPS is down by 41% YoY and by 5% from the previous quarter
The P/E is 34% below the 5-year quarterly average of 35.0 and 2.7% below the last 4 quarters average of 23.6
The P/B is 66% less than the 5-year quarterly average of 7.1 and 14% less than the last 4 quarters average of 2.8
AMED's equity is up by 12% year-on-year and by 2.6% since the previous quarter
The P/S is 54% less than the 5-year quarterly average of 2.5 and 11% less than the last 4 quarters average of 1.3

Efficiency

How efficient is Amedisys business performance
The ROE has contracted by 48% YoY and by 8% from the previous quarter
The ROA has declined by 46% year-on-year and by 5% since the previous quarter
The ROIC has contracted by 45% YoY
AMED's ROS is down by 33% YoY and by 2.4% from the previous quarter

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 139% higher than its total liabilities
The current ratio has increased by 12% YoY and by 6% QoQ
The company's total liabilities fell by 8% YoY and by 6% QoQ
The company's debt is 55% lower than its equity
The debt to equity has contracted by 20% YoY and by 12% from the previous quarter
AMED's equity is up by 12% year-on-year and by 2.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.